Concepedia

Publication | Closed Access

Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment

DOI

38

Citations

34

References

2021

Year

Chen‐Hua Liu, Chi-Yi Chen, Wei‐Wen Su, Kuo‐Chih Tseng, Chun‐Jen Liu, Jyh-Jou Chen, Cheng‐Yuan Peng, Yu‐Lueng Shih, Sheng‐Shun Yang, Chia‐Sheng Huang,
Gut

Abstract

SOF/VEL with or without low-dose RBV is effective and well-tolerated in HCV-infected patients with severe RI.

References

YearCitations

Page 1